Abstract
Purpose. The purpose of the present research was to study 10 m-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid—potential local anesthetics. The relationships between the structure of the molecule, its physicochemical parameters (log Doct, log k, RM, solubility) were correlated to the permeability data obtained from permeation experiments in Caco-2 monolayers and excised human skin in vitro.
Methods. The extent and mechanism(s) of permeability of the series were studied through a Caco-2 monolayer in the apical-to-basolateral (a-b) and basolateral-to-apical (b-a) directions. The MTT test was performed to determine cellular damage. In vitro transdermal permeability data were obtained from permeation experiments on excised human skin by using side-by-side chambers. Passive diffusion and iontophoretically enhanced permeability were measured.
Results. In Caco-2 monolayers, similar results in the shape of the permeability curves were obtained for the two directions. In the b-a direction, the values of Papp were ∼2-6 times greater than in the a-b direction. A plot of drug permeability vs. the number of carbons in the alkoxychain plateaued first, after which the permeability decreased by the increasing lipophilicity of the drug. If the log Doct of the ester was ≥ 3.4 and the MW > 385 Da, no measurable Caco-2 permeability was found. Cell damage was also higher by the more lipophilic compounds. In excised human skin, the relationship between the passive diffusion of the drugs and the number of carbons in the alkoxychain was parabolic (r 2 = 0.95). Introducing low-level electrical current (iontophoresis), transdermal permeability of the more hydrophilic phenylcarbamic acid esters increased clearly.
Conclusions. Lipophilicity and solubility of a compound have crucial roles in the permeation process. A very high lipophilicity has, however, a negative influence on the permeability, both intestinally and transdermally. Iontophoresis significantly increases the diffusion of small and less lipophilic compounds.
Similar content being viewed by others
REFERENCES
R. A. Conradi, P. S. Burton, and R. T. Borchardt. Physicochemical and biological factors that influence a drug's cellular permeability by passive diffusion. In: V. Pliška, B. Testa and H. van de Waterbeemd (eds.). Lipophilicity in Drug Action and Toxicology. VCH Weinheim, New York, Basel, Cambridge, Tokyo, 1996, pp. 233–252.
B. H. Stewart, O. H. Chan, R. H. Lu, E. L. Reyner, H. L. Schmid, H. W. Hamilton, B. A. Steinbauch, and M. D. Taylor. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm. Res. 12:693–699 (1995).
K. Palm, K. Luthman, A. L. Ungell, and P. Artursson. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 85:32–39 (1996).
G. Camenisch, J. Seuz, H. van de Waterbeemd, and G. Folkers. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6:313–319 (1998).
G. Camenisch, G. Folkers, and H. van de Waterbeemd. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. Eur. J. Pharm. Sci. 6:321–329 (1998).
G. L. Flynn. Mechanism of percutaneous absorption from physicochemical evidence. In: R. L. Bronaugh and H. I. Maibach (eds.). Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery. Marcel Dekker Inc., New York and Basel, 1989, pp. 27–51.
R. O. Potts and R. H. Guy. Predicting skin permeability. Pharm. Res. 9:663–669 (1992).
R. O. Potts and R. H. Guy. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 12:1628–1633 (1995).
M. Meylan and P. H. Howard. Atom/fragment contribution method for estimating octanol-water partition coefficient. J. Pharm. Sci. 84:83–91 (1995).
A. Pagliara, M. Reist, S. Geinoz, P. A. Carrupt, and B. Testa. Evaluation and prediction of drug permeation. J. Pharm. Pharmacol. 1:1339–1357 (1999).
P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 22:67–84 (1996).
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry.Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, BP, August 2000.
R. H. Guy. Current status and future prospects of transdermal drug delivery. Pharm. Res. 13:1765–1769 (1996).
J. Hirvonen, Y. N. Kalia, and R. H. Guy. Transdermal delivery of peptides by iontophoresis. Nature Biotechnol. 14:1710–1713 (1996).
J. Hirvonen and R. H. Guy. Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm. Res. 14:1258–1263 (1997).
J. Čižmárik, E. Polášek, P. Švec, and E. Racanská. ŠtÚdium lokálnych anestetík CX. Príprava, aktivita a rozdel'ovacie koeficienty pyrolidínoetylesterov 2-, 3-a 4-alkoxysubstituovaných kyselín fenylkarbámových, Čes. Slov. Farm. 42:88–91 (1993).
L. Gyürösiová, E. Sedlárová, and J. Čižmárik. Study of local anaesthetics, part 156: some physicochemical and lipophilic properties of o-, m-, p-alkoxysubstituted pyrrolidino-ethylesters of phenylcarbamic acid. Acta Poloniae Pharmaceutica. In press.
L. Jørgensen, P. Artursson, and E. Bechgaard. Toxicological and absorption enhancing effects of glycofurol 75 and sodium glycocholate in monolayers of human intestinal epithelial (Caco-2) cells. Int. J. Pharm. 95:209–217 (1993).
H. van de Waterbeemd, M. Kansy, B. Wagner, and H. Fisher. Lipophilicity measurement by reversed-phase high performance liquid chromatography (RP-HPLC). In: V. Pliska, B. Testa, and H. van de Waterbeemd (eds.). Lipophilicity in Drug Action and Toxicology. VCH Weinheim, New York, Basel, Cambridge, Tokyo, 1996, pp. 73–88.
H. Kubinyi. QSAR: Hansch Analysis and Approaches. VCH, Weinheim, New York, Basel, Cambridge, Tokyo, 1996.
G. Cimpan, M. Hadaruga, and V. Miclaus. Lipophilicity characterization by reversed-phase liquid chromatography of some furan derivates. J. Chromatogr. A 869:49–55 (2000).
O. Planis?k and S. Sr?i?. Some physicochemical properties of 7-oxoacyl-L-alanyl-D-isoglutamines. Int. J. Pharm. 187:199–207 (1999).
P. Artursson, A. L. Ungell, and J. E. Löfroth. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 10:123–1129 (1993).
F. Andriamainty and J. Čižmárik. Study of local anaesthetics. Part 154: study of micellization of the homologos of heptacainum chloride. C?s. Slov. Farm. In press.
J. T. Penniston, L. Beckett, D. L. Bentley, and C. Hansch. Passive permeation of organic compounds through biological tissues: a non-steady state theory. Mol. Pharmacol. 5:333–341 (1969).
O. Díez-Sales, A. C. Watkinson, M. Herráez-Dominguez, C. Javaloyes, and J. Hadgraft. A mechanistic investigation of the in vitro human skin permeation enhancing effect of Azone®. Int. J. Pharm. 129:33–40 (1996).
V. H. Le and B. C. Lippold. Influence of physicochemical properties of homologous esters of nicotinic acid on skin permeability and maximum flux. Int. J. Pharm. 124:285–292 (1995).
K. Kontturi and L. Murtomäki. Mechanistic model for transdermal transport including iontophoresis. J. Control. Release 41:177–185 (1996).
K. C. Sung, J. Y. Fang, and O. Y. P. Hu. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. J. Control. Release 67:1–8 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gyürösiová, L., Laitinen, L., Raiman, J. et al. Permeability Profiles of M-Alkoxysubstituted Pyrrolidinoethylesters of Phenylcarbamic Acid Across Caco-2 Monolayers and Human Skin. Pharm Res 19, 162–168 (2002). https://doi.org/10.1023/A:1014208515545
Issue Date:
DOI: https://doi.org/10.1023/A:1014208515545